
Publication 📃! We explored the #lungmicrobiota of post-COVID patients with lung abnormalities. 🧫Read more here: publications.ersnet.org/cont… !! @drphilmol @ImperialNHLI @RBandH @ImperialNHS

Budding scientist 9-5. Postdoc in ICL looking at IPF.

Publication 📃! We explored the #lungmicrobiota of post-COVID patients with lung abnormalities. 🧫Read more here: publications.ersnet.org/cont… !! @drphilmol @ImperialNHLI @RBandH @ImperialNHS

Thanks @hall_lab and @RobinsonLab_QIB 🎉

In the lab we saw that supernatant of B.fragilis released more LDH in #BreastCancer cells in a dose-dependent manner which didn't translate to cell death. 🤨

Oral #Streptococcus was high at baseline samples in clinical benefit patients. #lefse showed that #Bacteroidesfragilis was associated in the gut microbiota of clinical benefit patients.

We found that pembrolizumab and eribulin did not confer either gut or oral microbiota toxicity. Functional potential of the gut microbiota was similar between patients that responded and those who didn't.


Paper from my #PhD is out! We profiled the gut and oral #microbiome of metastatic #breastcancer patients. This project was a long one in collaboration with @wearemedsir. Thanks @TheQuadram @bigctweets for supporting my studentship. It's published 🎉. oaepublish.com/articles/mrr.…

We have an open #postdoc position (#microbiology/#microbiome) for our ERC Starting Grant and Emmy Noether project. Join us to work on host-microbial interactions and their role in human health! @TU_Muenchen @ERC_Research #DFG #postdocjobs tinyurl.com/atvawt3k Please RT.

Love #SciCommChat? We need your help! Please help us grow this community by promoting our chat in your content. Tell all your #SciComm friends about us. Write about us on your Twitter, LinkedIn, Insta, Facebook, TikTok, blog posts, and wherever else! Pretty please! 🥺🙏🏽🥺

Two proud PhD supervisors today @hall_lab & @RobinsonLab_QIB! Huge congrats to @nteng18 on passing her viva with only minor corrections 🥳 Nancys @bigctweets PhD work was on #microbiome & #breastcancer with exciting outputs tbc..! Thanks to examiners @ae_mather & @Caketin_Wade!

Novel bacterial isolates from patient samples at Norwich & Norfolk University Hospital: Allocoprobacillus halotolerans and Coprobacter tertius. Published #OpenAccess and fee-free in #IJSEM using a #PublishAndRead agreement. doi.org/10.1099/ijsem.0.0059…

Very excited for my review published in Current Opinion in Microbiology. This review explores the current understanding of the infant skin microbiome and research challenges. @ma_webber @hall_lab @TheQuadram @sciencedirect @ElsevierConnect @ElsevierNews sciencedirect.com/science/ar…

In exciting news, I have a preprint to share. This is with @hall_lab with help from @raymond_kiu and in collaboration with @sharonecox15 and her colleagues in Cambodia and Japan. This explores the gut microbiota of infants in a rural part of Cambodia. biorxiv.org/content/10.1101/…

Excited for my new publication on an optimised DNA extraction method from infant skin for short and long read shotgun metagenomic sequencing and downstream analysis. @ma_webber @hall_lab @TheQuadram @Unilever @MicrobioSoc 🧬🧬🧬🧬🧬🧬🧬🧬🧬🧬🧬🧬🧬 microbiologyresearch.org/con…

(9/9) Thank you to everyone at @TheQuadram and @TU_Muenchen for the help. Special shout out to @raymond_kiu @hall_lab @ChristianZenne5 @QIBSequencing and @RobinsonLab_QIB for the support.

(8/9) The highest ANI was to Coprobacter secundus, 77.81%. Phenotypically it was similar to its siblings however it could not tolerate ox gall unlike its siblings. Being the third species of the genus Coprobacter we named it Coprobacter tertius.